Roche Holding AG (LON:0QOK)

Market Cap	280.57B +38.2%
Revenue (ttm)	59.37B +1.5%
Net Income	12.07B +55.6%
EPS	15.03 +55.6%
Shares Out	n/a
PE Ratio	23.25
Forward PE	18.02
Dividend	8.49 (2.31%)
Ex-Dividend Date	Mar 27, 2025

Volume	503,954
Average Volume	473,952
Open	369.10
Previous Close	368.19
Day's Range	363.80 - 369.80
52-Week Range	221.30 - 373.70
Beta	0.20
RSI	71.06
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavir...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,249
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QOK

Financial Performance

In 2025, Roche Holding AG's revenue was 63.36 billion, an increase of 1.54% compared to the previous year's 62.40 billion. Earnings were 12.88 billion, an increase of 55.61%.

Financial numbers in CHF